Sort
17,828 grants matching “crispr”
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
$677,102Cornelia M Ulrich · University Of Utah · R01 · FY2021 · CA
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
$676,729Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
Exploiting cell fate transition to overcome radiation resistance in glioblastoma
$676,623Erik Sulman · New York University School Of Medicine · R01 · FY2025 · CA
In vivo delivery of engineered tRNAs for suppression of nonsense mutations
$676,428John D. Lueck · University Of Rochester · R01 · FY2023 · HL
A high-performance and versatile technology for precision microbiome engineering
$676,224Harris H Wang · Columbia University Health Sciences · R01 · FY2022 · EB
Nutrigenomics of Intestinal Vitamin D Action
$676,221Sylvia S Christakos · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DK
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
$675,989Joseph C Wu · Stanford University · R01 · FY2023 · HL
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk
$675,980Thomas None Quertermous · Stanford University · R01 · FY2021 · HL
Directing fate, subtype identity and survival in human pluripotent-derived midbrain dopamine neurons
$675,698Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2021 · NS
New tools for quantitative non-invasive recording of biochemical signals
$675,594Nathan Christopher Shaner · University Of California, San Diego · R01 · FY2024 · CA
Cellular dissection of herpes simplex encephalitis with iPS cells
$675,297Jean-Laurent Casanova · Rockefeller University · R01 · FY2018 · NS
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
$675,266Joseph C Wu · Stanford University · R01 · FY2025 · HL
Integrative Characterization on the function of COPD GWAS gene, HHIP
$675,259Anny Xiaobo Zhou · Brigham And Women'S Hospital · R01 · FY2020 · HL
Corrective editing to treat phenylketonuria
$675,157Xiao Wang · University Of Pennsylvania · R01 · FY2024 · HD
Corrective editing to treat phenylketonuria
$675,157Xiao Wang · University Of Pennsylvania · R01 · FY2025 · HD
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk
$675,112Thomas None Quertermous · Stanford University · R01 · FY2023 · HL
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk
$675,112Thomas None Quertermous · Stanford University · R01 · FY2022 · HL
Craniofacial Developmental Dynamics
$674,880Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
The role of AU-rich element binding proteins in shaping target mRNA expression
$674,784Markus Hafner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
CRISPRa-based rescue of sensorimotor deficits in the Scn2a+/- mouse model of autism spectrum disorder
$674,656Kevin J Bender · University Of California, San Francisco · R01 · FY2024 · MH
From Obesity GWAS to therapeutic targets
$674,421Christian Vaisse · University Of California, San Francisco · R01 · FY2024 · DK
Protein kinase C and lung carcinogenesis
$674,373Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2023 · CA
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
$673,965Daniel H Geschwind · Icahn School Of Medicine At Mount Sinai · U54 · FY2025 · NS
Effects of Interferon on primate lentiviruses
$673,658Theodora Hatziioannou · Rockefeller University · R01 · FY2025 · AI
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
$673,652Paul J Brindley · George Washington University · R01 · FY2018 · CA